SHH:688089

Cabio Biotech (Wuhan) Co., Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:40 UTC

Last close

n/aCNY

Market data

8.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

297

2016-12-31 to 2025-12-31100 at the start297

Sales: 100.00 on 2016-12-31 to 296.69 on 2025-12-31, up 197%.

Profit

306

2016-12-31 to 2025-12-31100 at the start306

Profit: 100.00 on 2016-12-31 to 306.03 on 2025-12-31, up 206%.

Shares in issue

132

2016-12-31 to 2025-12-31100 at the start132

Shares in issue: 100.00 on 2016-12-31 to 131.83 on 2025-12-31, up 32%.

Sales is at 297, Profit is at 306, Shares in issue is at 132, against 100 in 2016.

Sales is at 297, Profit is at 306, Shares in issue is at 132, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100297
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100306
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100132
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY